What is the current annual D&A of NVAX?

As of today, NVAX annual D&A is $27.61M

What is 1-year change in NVAX annual D&A?

NVAX annual D&A is down -43.06% year-over-year

What is 3-year change in NVAX annual D&A?

NVAX annual D&A is down -4.96% over the past 3 years

How far is NVAX annual D&A from its all-time high?

NVAX annual D&A is currently -43.06% below its historical high of $48.50M set on December 31, 2024

How does NVAX annual D&A rank versus sector peers?

NVAX annual D&A is higher than 80.58% of companies in Healthcare sector

When is NVAX next annual earnings release?

As of today, the next annual earnings release for NVAX has not been scheduled

What is the current quarterly D&A of NVAX?

As of today, NVAX quarterly D&A is $3.06M

What is NVAX quarterly D&A most recent change?

NVAX quarterly D&A was down -40.25% on March 31, 2026

What is 1-year change in NVAX quarterly D&A?

NVAX quarterly D&A is down -63.29% year-over-year

How far is NVAX quarterly D&A from its all-time high?

NVAX quarterly D&A is currently -75.89% below its historical high of $12.70M set on September 30, 2024

How does NVAX quarterly D&A rank versus sector peers?

NVAX quarterly D&A is higher than 70.45% of companies in Healthcare sector

When is NVAX next earnings release?

The next earnings release for NVAX is on August 5, 2026

What is the current TTM D&A of NVAX?

As of today, NVAX TTM D&A is $22.34M

What is NVAX TTM D&A most recent change?

NVAX TTM D&A was down -19.11% on March 31, 2026

What is 1-year change in NVAX TTM D&A?

NVAX TTM D&A is down -50.02% year-over-year

How far is NVAX TTM D&A from its all-time high?

NVAX TTM D&A is currently -53.94% below its historical high of $48.50M set on December 31, 2024

How does NVAX TTM D&A rank versus sector peers?

NVAX TTM D&A is higher than 76.45% of companies in Healthcare sector

When is NVAX next earnings release?

The next earnings release for NVAX is on August 5, 2026

Novavax, Inc. (NVAX) Depreciation And Amortization History & Chart

Annual D&A

$27.61M$20.88M-43.06%

December 31, 2025

Summary

Current Value: As of today, NVAX annual D&A is $27.61M, down -43.06% on December 31, 2025
Historical Performance: NVAX annual D&A is down -4.96% over the past 3 years, up +465.26% over the past 5 years
All-Time High Comparison: NVAX annual D&A is currently -43.06% below its historical high of $48.50M set on December 31, 2024
3-Year Low Comparison: NVAX annual D&A is at its 3-year low
Sector Comparison: NVAX annual D&A is higher than 80.58% of companies in Healthcare sector

Depreciation & Amortization Chart

Performance

NVAX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
	Dec 31, 25	$27.61M	-43.1%	-5.0%	+465.3%	+1912.6%
	Mar 31, 26	$3.06M	-63.3%	-66.1%	+32.1%	+687.1%
	Mar 31, 26	$22.34M	-50.0%	-28.7%	+255.8%	+1960.4%
Price	May 14, 26	$9.35	+48.6%	+15.3%	-92.9%	-79.9%
	Dec 31, 25	$157.48M	-53.3%	-67.8%	+8.4%	+1357.5%
	Dec 31, 25	$683.18M	-21.4%	-74.1%	-23.6%	+1795.0%
	Dec 31, 25	$489.07M	-31.7%	-71.6%	+18.1%	+1170.5%
	Dec 31, 25	$1.12B	+64.7%	-43.3%	+136.2%	+10000.0%

Depreciation & Amortization Highs

NVAX Annual D&A Highs Comparison
Period	High	Date	Current
3Y	$48.50M	Dec 31, 24	-43.1%
5Y	$48.50M	Dec 31, 24	-43.1%
All	$48.50M	Dec 31, 24	-43.1%

Depreciation & Amortization Lows

NVAX Annual D&A Lows Comparison
Period	Low	Date	Current
3Y	$27.61M	Dec 31, 25	at low
5Y	$4.89M	N/A	+465.3%
All	$253.60K	Dec 31, 97	>+9999.0%

Depreciation & Amortization History

Year	Value	Change
2025	$27.61M	-43.1%
2024	$48.50M	+17.6%
2023	$41.23M	+41.9%
2022	$29.05M	+129.5%
2021	$12.66M	+159.2%
2020	$4.89M	-13.9%
2019	$5.68M	-30.4%
2018	$8.16M	-16.9%
2017	$9.82M	+15.4%
2016	$8.51M	+42.2%
2015	$5.98M	+35.2%
2014	$4.42M	+70.7%
2013	$2.59M	+55.5%
2012	$1.67M	+3.3%
2011	$1.61M	+17.6%
2010	$1.37M	+14.9%

Year	Value	Change
2009	$1.19M	+33.7%
2008	$893.00K	+7.1%
2007	$834.00K	-72.7%
2006	$3.05M	-12.1%
2005	$3.48M	+13.8%
2004	$3.05M	+157.4%
2003	$1.19M	+4.2%
2002	$1.14M	-67.4%
2001	$3.49M	+487.4%
2000	$594.00K	+55.5%
1999	$382.00K	+35.9%
1998	$281.00K	+10.8%
1997	$253.60K	-22.7%
1996	$328.20K	+20.3%
1995	$272.90K	-

FAQ

What is the current annual D&A of NVAX?
As of today, NVAX annual D&A is $27.61M
What is 1-year change in NVAX annual D&A?
NVAX annual D&A is down -43.06% year-over-year
What is 3-year change in NVAX annual D&A?
NVAX annual D&A is down -4.96% over the past 3 years
How far is NVAX annual D&A from its all-time high?
NVAX annual D&A is currently -43.06% below its historical high of $48.50M set on December 31, 2024
How does NVAX annual D&A rank versus sector peers?
NVAX annual D&A is higher than 80.58% of companies in Healthcare sector
When is NVAX next annual earnings release?
As of today, the next annual earnings release for NVAX has not been scheduled

Quarterly D&A

$3.06M$2.06M-40.25%

March 31, 2026

Summary

Current Value: As of today, NVAX quarterly D&A is $3.06M, down -40.25% on March 31, 2026
Historical Performance: NVAX quarterly D&A is down -63.29% year-over-year, down -66.14% over the past 3 years
All-Time High Comparison: NVAX quarterly D&A is currently -75.89% below its historical high of $12.70M set on September 30, 2024
3-Year Low Comparison: NVAX quarterly D&A is at its 3-year low
Sector Comparison: NVAX quarterly D&A is higher than 70.45% of companies in Healthcare sector

Performance

NVAX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
	Mar 31, 26	$3.06M	-40.3%	-63.3%	-66.1%	+32.1%
	Dec 31, 25	$27.61M	–	-43.1%	-5.0%	+465.3%
	Mar 31, 26	$22.34M	-19.1%	-50.0%	-28.7%	+255.8%
Price	May 14, 26	$9.35	+7.5%	+48.6%	+15.3%	-92.9%
	Mar 31, 26	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
	Mar 31, 26	$149.01M	+15.0%	+0.7%	-60.3%	-77.8%
	Mar 31, 26	$118.89M	+17.8%	-13.1%	-68.0%	-43.0%
	Mar 31, 26	$139.51M	-5.2%	-79.1%	+72.3%	-68.8%

Quarterly D&A Highs

NVAX Quarterly D&A Highs Comparison
Period	High	Date	Current
1Y	$8.34M	N/A	-63.3%
3Y	$12.70M	Sep 30, 24	-75.9%
5Y	$12.70M	Sep 30, 24	-75.9%
All	$12.70M	Sep 30, 24	-75.9%

Quarterly D&A Lows

NVAX Quarterly D&A Lows Comparison
Period	Low	Date	Current
1Y	$3.06M	Mar 31, 26	at low
3Y	$3.06M	Mar 31, 26	at low
5Y	$2.32M	N/A	+32.1%
All	-$1.36M	Dec 31, 07	+325.0%

Quarterly D&A History

Month	Value	Change
Mar 2026	$3.06M	-40.3%
Dec 2025	$5.13M	-22.2%
Sep 2025	$6.59M	-12.9%
Jun 2025	$7.56M	-9.3%
Mar 2025	$8.34M	-33.4%
Dec 2024	$12.52M	-1.4%
Sep 2024	$12.70M	+14.1%
Jun 2024	$11.13M	-8.4%
Mar 2024	$12.15M	+12.5%
Dec 2023	$10.79M	-4.7%
Sep 2023	$11.32M	+12.5%
Jun 2023	$10.07M	+11.3%
Mar 2023	$9.04M	+25.2%
Dec 2022	$7.22M	-13.5%
Sep 2022	$8.35M	+24.2%
Jun 2022	$6.72M	-0.7%
Mar 2022	$6.77M	+84.2%
Dec 2021	$3.67M	-13.8%
Sep 2021	$4.26M	+76.8%
Jun 2021	$2.41M	+4.0%
Mar 2021	$2.32M	+29.2%
Dec 2020	$1.79M	+51.3%
Sep 2020	$1.19M	+21.0%
Jun 2020	$980.00K	+5.9%
Mar 2020	$925.00K	-0.8%
Dec 2019	$932.00K	+5.9%
Sep 2019	$880.00K	-54.3%
Jun 2019	$1.93M	-0.7%
Mar 2019	$1.94M	-2.2%
Dec 2018	$1.98M	-2.9%
Sep 2018	$2.04M	-0.8%
Jun 2018	$2.06M	-1.1%
Mar 2018	$2.08M	-2.0%
Dec 2017	$2.12M	-39.9%
Sep 2017	$3.53M	+71.6%
Jun 2017	$2.06M	-2.6%
Mar 2017	$2.11M	-4.8%
Dec 2016	$2.22M	-0.1%
Sep 2016	$2.22M	+5.2%
Jun 2016	$2.11M	+8.1%
Mar 2016	$1.95M	+19.4%
Dec 2015	$1.64M	+5.4%
Sep 2015	$1.55M	+4.4%
Jun 2015	$1.49M	+13.5%
Mar 2015	$1.31M	-8.4%
Dec 2014	$1.43M	+37.5%
Sep 2014	$1.04M	+6.5%
Jun 2014	$976.00K	-0.4%
Mar 2014	$980.00K	+2.6%
Dec 2013	$955.00K	+41.5%
Sep 2013	$675.00K	+31.8%
Jun 2013	$512.00K	+14.0%
Mar 2013	$449.00K	-0.2%
Dec 2012	$450.00K	+10.8%
Sep 2012	$406.00K	0.0%
Jun 2012	$406.00K	+0.5%
Mar 2012	$404.00K	-2.9%
Dec 2011	$416.00K	+1.7%
Sep 2011	$409.00K	+2.5%
Jun 2011	$399.00K	+2.6%

Month	Value	Change
Mar 2011	$389.00K	+8.7%
Sep 2010	$358.00K	+6.2%
Jun 2010	$337.00K	+13.9%
Mar 2010	$296.00K	+0.3%
Dec 2009	$295.00K	-0.7%
Sep 2009	$297.00K	+44.9%
Jun 2009	$205.00K	-48.4%
Mar 2009	$397.00K	+27.2%
Dec 2008	$312.00K	+93.8%
Sep 2008	$161.00K	+47.7%
Jun 2008	$109.00K	-65.0%
Mar 2008	$311.00K	+122.9%
Dec 2007	-$1.36M	-288.0%
Sep 2007	$724.00K	-1.0%
Jun 2007	$731.00K	-1.2%
Mar 2007	$740.00K	-5.1%
Dec 2006	$780.00K	+1.3%
Sep 2006	$770.00K	+1.7%
Jun 2006	$757.00K	+1.5%
Mar 2006	$746.00K	-0.1%
Dec 2005	$747.00K	-14.2%
Sep 2005	$871.00K	-6.6%
Jun 2005	$933.00K	+1.0%
Mar 2005	$924.00K	+3.9%
Dec 2004	$889.00K	+10.0%
Sep 2004	$808.00K	+14.1%
Jun 2004	$708.00K	+9.3%
Mar 2004	$648.00K	+107.7%
Dec 2003	$312.00K	+0.3%
Sep 2003	$311.00K	+9.9%
Jun 2003	$283.00K	+1.1%
Mar 2003	$280.00K	-0.4%
Dec 2002	$281.00K	0.0%
Sep 2002	$281.00K	+0.4%
Jun 2002	$280.00K	-5.4%
Mar 2002	$296.00K	-67.5%
Dec 2001	$911.00K	+6.1%
Sep 2001	$859.00K	-8.1%
Jun 2001	$935.00K	+19.3%
Mar 2001	$784.00K	+175.1%
Dec 2000	$285.00K	+176.7%
Sep 2000	$103.00K	-1.0%
Jun 2000	$104.00K	+2.0%
Mar 2000	$102.00K	-20.3%
Dec 1999	$128.00K	+11.3%
Sep 1999	$115.00K	+66.7%
Jun 1999	$69.00K	-1.4%
Mar 1999	$70.00K	-15.3%
Dec 1998	$82.60K	+25.2%
Sep 1998	$66.00K	+0.8%
Jun 1998	$65.50K	-2.1%
Mar 1998	$66.90K	-33.1%
Dec 1997	$100.00K	0.0%
Sep 1997	$100.00K	>+9,900.0%
Jun 1997	$0.00	-100.0%
Mar 1997	$100.00K	0.0%
Dec 1996	$100.00K	>+9,900.0%
Sep 1996	$0.00	-100.0%
Jun 1996	$100.00K	0.0%
Mar 1996	$100.00K	-

FAQ

What is the current quarterly D&A of NVAX?
As of today, NVAX quarterly D&A is $3.06M
What is NVAX quarterly D&A most recent change?
NVAX quarterly D&A was down -40.25% on March 31, 2026
What is 1-year change in NVAX quarterly D&A?
NVAX quarterly D&A is down -63.29% year-over-year
How far is NVAX quarterly D&A from its all-time high?
NVAX quarterly D&A is currently -75.89% below its historical high of $12.70M set on September 30, 2024
How does NVAX quarterly D&A rank versus sector peers?
NVAX quarterly D&A is higher than 70.45% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on August 5, 2026

TTM D&A

$22.34M$5.28M-19.11%

March 31, 2026

Summary

Current Value: As of today, NVAX TTM D&A is $22.34M, down -19.11% on March 31, 2026
Historical Performance: NVAX TTM D&A is down -50.02% year-over-year, down -28.72% over the past 3 years
All-Time High Comparison: NVAX TTM D&A is currently -53.94% below its historical high of $48.50M set on December 31, 2024
3-Year Low Comparison: NVAX TTM D&A is at its 3-year low
Sector Comparison: NVAX TTM D&A is higher than 76.45% of companies in Healthcare sector

Performance

NVAX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
	Mar 31, 26	$22.34M	-19.1%	-50.0%	-28.7%	+255.8%
	Dec 31, 25	$27.61M	–	-43.1%	-5.0%	+465.3%
	Mar 31, 26	$3.06M	-40.3%	-63.3%	-66.1%	+32.1%
Price	May 14, 26	$9.35	+7.5%	+48.6%	+15.3%	-92.9%
	Mar 31, 26	-$18.11B	-10000.0%	-6169.1%	-3685.4%	-9198.3%
	Mar 31, 26	$596.34M	-46.9%	-52.5%	-56.1%	-35.1%

TTM D&A Highs

NVAX TTM D&A Highs Comparison
Period	High	Date	Current
1Y	$44.69M	N/A	-50.0%
3Y	$48.50M	Dec 31, 24	-53.9%
5Y	$48.50M	Dec 31, 24	-53.9%
All	$48.50M	Dec 31, 24	-53.9%

TTM D&A Lows

NVAX TTM D&A Lows Comparison
Period	Low	Date	Current
1Y	$22.34M	Mar 31, 26	at low
3Y	$22.34M	Mar 31, 26	at low
5Y	$6.28M	N/A	+255.8%
All	-$780.00K	Sep 30, 08	+2963.5%

TTM D&A History

Month	Value	Change
Mar 2026	$22.34M	-19.1%
Dec 2025	$27.61M	-21.1%
Sep 2025	$35.01M	-14.9%
Jun 2025	$41.12M	-8.0%
Mar 2025	$44.69M	-7.9%
Dec 2024	$48.50M	+3.7%
Sep 2024	$46.77M	+3.0%
Jun 2024	$45.39M	+2.4%
Mar 2024	$44.33M	+7.5%
Dec 2023	$41.23M	+9.5%
Sep 2023	$37.65M	+8.6%
Jun 2023	$34.68M	+10.7%
Mar 2023	$31.33M	+7.8%
Dec 2022	$29.05M	+13.9%
Sep 2022	$25.50M	+19.1%
Jun 2022	$21.42M	+25.2%
Mar 2022	$17.11M	+35.1%
Dec 2021	$12.66M	+17.4%
Sep 2021	$10.78M	+39.9%
Jun 2021	$7.71M	+22.8%
Mar 2021	$6.28M	+28.5%
Dec 2020	$4.89M	+21.4%
Sep 2020	$4.02M	+8.2%
Jun 2020	$3.72M	-20.3%
Mar 2020	$4.66M	-17.9%
Dec 2019	$5.68M	-15.6%
Sep 2019	$6.73M	-14.7%
Jun 2019	$7.89M	-1.6%
Mar 2019	$8.02M	-1.7%
Dec 2018	$8.16M	-1.7%
Sep 2018	$8.30M	-15.2%
Jun 2018	$9.79M	+0.0%
Mar 2018	$9.79M	-0.3%
Dec 2017	$9.82M	-1.0%
Sep 2017	$9.91M	+15.2%
Jun 2017	$8.61M	-0.6%
Mar 2017	$8.66M	+1.8%
Dec 2016	$8.51M	+7.3%
Sep 2016	$7.92M	+9.2%
Jun 2016	$7.25M	+9.4%
Mar 2016	$6.63M	+10.8%
Dec 2015	$5.98M	+3.6%
Sep 2015	$5.78M	+9.7%
Jun 2015	$5.26M	+10.7%
Mar 2015	$4.75M	+7.4%
Dec 2014	$4.42M	+12.0%
Sep 2014	$3.95M	+10.2%
Jun 2014	$3.59M	+14.9%
Mar 2014	$3.12M	+20.5%
Dec 2013	$2.59M	+24.2%
Sep 2013	$2.09M	+14.8%
Jun 2013	$1.82M	+6.2%
Mar 2013	$1.71M	+2.7%
Dec 2012	$1.67M	+2.1%
Sep 2012	$1.63M	-0.2%
Jun 2012	$1.64M	+0.4%
Mar 2012	$1.63M	+0.9%
Dec 2011	$1.61M	+34.8%
Sep 2011	$1.20M	+4.5%
Jun 2011	$1.15M	+5.7%

Month	Value	Change
Mar 2011	$1.08M	-15.7%
Sep 2010	$1.29M	+5.0%
Jun 2010	$1.23M	+12.1%
Mar 2010	$1.09M	-8.5%
Dec 2009	$1.19M	-1.4%
Sep 2009	$1.21M	+12.7%
Jun 2009	$1.08M	+9.8%
Mar 2009	$979.00K	+9.6%
Dec 2008	$893.00K	+214.5%
Sep 2008	-$780.00K	-259.4%
Jun 2008	-$217.00K	-153.6%
Mar 2008	$405.00K	-51.4%
Dec 2007	$834.00K	-72.0%
Sep 2007	$2.98M	-1.5%
Jun 2007	$3.02M	-0.9%
Mar 2007	$3.05M	-0.2%
Dec 2006	$3.05M	+1.1%
Sep 2006	$3.02M	-3.2%
Jun 2006	$3.12M	-5.3%
Mar 2006	$3.30M	-5.1%
Dec 2005	$3.48M	-3.9%
Sep 2005	$3.62M	+1.8%
Jun 2005	$3.55M	+6.8%
Mar 2005	$3.33M	+9.0%
Dec 2004	$3.05M	+23.3%
Sep 2004	$2.48M	+25.1%
Jun 2004	$1.98M	+27.3%
Mar 2004	$1.55M	+31.0%
Dec 2003	$1.19M	+2.7%
Sep 2003	$1.16M	+2.7%
Jun 2003	$1.13M	+0.3%
Mar 2003	$1.12M	-1.4%
Dec 2002	$1.14M	-35.6%
Sep 2002	$1.77M	-24.6%
Jun 2002	$2.35M	-21.8%
Mar 2002	$3.00M	-14.0%
Dec 2001	$3.49M	+21.9%
Sep 2001	$2.86M	+35.9%
Jun 2001	$2.11M	+65.1%
Mar 2001	$1.28M	+114.8%
Dec 2000	$594.00K	+35.9%
Sep 2000	$437.00K	-2.7%
Jun 2000	$449.00K	+8.5%
Mar 2000	$414.00K	+8.4%
Dec 1999	$382.00K	+13.5%
Sep 1999	$336.60K	+17.0%
Jun 1999	$287.60K	+1.2%
Mar 1999	$284.10K	+1.1%
Dec 1998	$281.00K	-5.8%
Sep 1998	$298.40K	-10.2%
Jun 1998	$332.40K	+24.5%
Mar 1998	$266.90K	-11.0%
Dec 1997	$300.00K	0.0%
Sep 1997	$300.00K	+50.0%
Jun 1997	$200.00K	-33.3%
Mar 1997	$300.00K	0.0%
Dec 1996	$300.00K	+50.0%
Sep 1996	$200.00K	0.0%
Jun 1996	$200.00K	+100.0%
Mar 1996	$100.00K	-

FAQ

What is the current TTM D&A of NVAX?
As of today, NVAX TTM D&A is $22.34M
What is NVAX TTM D&A most recent change?
NVAX TTM D&A was down -19.11% on March 31, 2026
What is 1-year change in NVAX TTM D&A?
NVAX TTM D&A is down -50.02% year-over-year
How far is NVAX TTM D&A from its all-time high?
NVAX TTM D&A is currently -53.94% below its historical high of $48.50M set on December 31, 2024
How does NVAX TTM D&A rank versus sector peers?
NVAX TTM D&A is higher than 76.45% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on August 5, 2026

Data Sources & References

NVAX Official Website www.novavax.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069426000007/0001000694-26-000007-index.htm
NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax